VeriMomtripeptide-23 est-il sûr pendant la grossesse ?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment found for tripeptide-23, and no peer-reviewed reproductive or developmental toxicity data were identified; peptides of this size are generally not expected to be systemically absorbed from topical use, so default hazard/mechanism/exposure scores are 0. Sources checked: ECHA Annex VI (no harmonised classification), PubMed (no reproductive/developmental studies), CosIng/PubChem (ingredient listings only).
Related ingredients
Frequently asked questions
- tripeptide-23 est-il sûr pendant la grossesse ?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment found for tripeptide-23, and no peer-reviewed reproductive or developmental toxicity data were identified; peptides of this size are generally not expected to be systemically absorbed from topical use, so default hazard/mechanism/exposure scores are 0. Sources checked: ECHA Annex VI (no harmonised classification), PubMed (no reproductive/developmental studies), CosIng/PubChem (ingredient listings only).
- tripeptide-23 est-il sûr pendant l'allaitement ?
- No evidence of reproductive or lactation-specific toxicity or systemic exposure from topical use in available sources; no SCCS/CIR assessment indicating risk. Same rationale as pregnancy: no data indicating hazard or mechanism, and expected negligible dermal absorption for a short synthetic peptide. Sources: SCCS/CIR none found, PubMed none found, CosIng/PubChem ingredient entries.
- tripeptide-23 est-il sûr pour la peau de bébé ?
- No infant-specific toxicity or developmental studies found. Adult exposure scored as negligible (0) given peptide size and lack of systemic data; per instructions, exposure score increased by +1 for baby skin because infant barrier is immature and topical absorption can be higher even when adult absorption is expected to be negligible. No evidence to increase hazard or mechanism scores. Sources: PubMed (no infant studies), CosIng, PubChem, ECHA Annex VI (no harmonised classification).
- Comment VeriMom évalue-t-il tripeptide-23 ?
- VeriMom évalue tripeptide-23 à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à tripeptide-23 pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à tripeptide-23 basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.